{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided has multiple entries with the title \"Estimating the number of infections and the impact of non-\" followed by \"Passage: Lockdown\" and one entry with \"banned Implemented with lockdown.57 24/3/2020\". \n\nFirst, I need to figure out what the context is. The titles mention estimating infections and the impact of non-... but the passage just says \"Lockdown\" each time. The last entry has \"banned Implemented with lockdown.57 24/3/2020\". Maybe that's a typo or part of a larger text. The date 24/3/2020 is March 24, 2020, which is around when many countries started lockdowns due to the pandemic.\n\nSince the context is limited, I need to rely on my existing knowledge. A lockdown is a public health measure where people are required to stay at home to prevent the spread of a disease, like COVID-19. It involves restricting movement, closing non-essential businesses, and limiting gatherings. The context mentions the impact of non-... which might be \"non-pharmaceutical interventions\" (NPIs), which include lockdowns. The date in the last entry could refer to when a lockdown was implemented in a specific place.\n\nBut the user's answer should be based on the provided context. However, the context here is very minimal. The passages just say \"Lockdown\" and one mentions \"banned Implemented with lockdown.57 24/3/2020\". Maybe the \"banned\" part is a typo for \"ban\" or another word. The number 57 could be a reference to a study or a section. The date is March 24, 2020, which is when the UK announced a lockdown, for example.\n\nPutting it all together, the answer should define a lockdown as a public health measure to restrict movement and gatherings to control disease spread, possibly referencing the context's mention of its implementation on March 24, 2020. However, since the context is sparse, the answer should be concise and based on general knowledge but framed within the given context.\n</think>\n\nA lockdown is a public health measure implemented to restrict movement and gatherings in order to slow the spread of infectious diseases, such",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which is Chikungunya virus. I need to look through the provided context to find all the mentioned complications.\n\nFirst, the first passage lists several complications from most common to least. Let me check that again. It says: respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. So those are the main ones mentioned there.\n\nThen, looking at the second part of the passage, there's mention of neonates. It says that mothers can transmit CHIKV during the perinatal period, leading to high morbidity. The neonates showed symptoms by day 4, and six had meningoencephalitis. Another part mentions nineteen cases of neonatal infection leading to encephalitis due to vertical transmission. So encephalitis is a complication here, specifically in neonates.\n\nWait, the first passage already listed meningoencephalitis as a complication. So encephalitis is part of that? Or is it a separate point? The first part lists meningoencephalitis as a common complication, and then the neonatal cases mention encephalitis. Maybe encephalitis is included under central nervous system problems mentioned in the first list. The first passage says \"other central nervous system problems\" as a less common complication. So maybe encephalitis is part of that category. But in the neonatal cases, it's specifically mentioned as encephalitis. So perhaps both meningoencephalitis and encephalitis are separate complications, but the first list groups them under central nervous system issues. \n\nI need to make sure I include all the complications mentioned. Let me list them again:\n\nFrom the first passage:\n- Respiratory failure\n- Cardiovascular decompensation\n- Meningoencephalitis\n- Severe acute hepatitis\n- Severe cutaneous effects\n- Other central nervous system problems\n- Kidney failure\n\nFrom the second part:\n- Neonatal encephalitis (due to vertical transmission)\n- High morbidity in neonates\n- Symptoms in neonates by day 4 of life\n\nSo the answer should include all these complications. Also, the user might want them listed in order of commonness as per the first passage. The first",
      "retrieved_chunks": [
        "Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "Passage: and complications.",
        "reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers .",
        "Title: Chikungunya: A Potentially Emerging Epidemic?"
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.2,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what the answer is here. The user is asking, \"What does Clade A contain?\" based on the provided context. Let me start by reading through the context carefully.\n\nFirst, the context mentions several clades like 1B.1, 1B.2, 1A.1, 1C.2, etc. The main discussion revolves around APD (Average Pairwise Distance) thresholds. The key points are that each clade generally has an APD greater than 7% from other clades and less than 7% within the clade. There are exceptions, such as 1B.1 and 1B.2, where the within-clade APD didn't meet the criteria. Similarly, 1A.1 and 1A.1.1 had exceptions. The 1C lineage is mentioned with 315 viruses from China and South Korea, and there's a mention of \"Other-Avian\" clades. The 1B human seasonal lineage's APDs are in Table 3.\n\nNow, the question is about \"Clade A.\" But looking through the context, I don't see any mention of a clade labeled \"A.\" The clades discussed are 1A.1, 1B.1, 1B.2, 1C.2, etc. The titles and passages refer to lineages like 1C, 1B human seasonal, etc. There's no specific information about a standalone \"Clade A.\" The closest is 1A.1, which is part of the 1A lineage. The user might be confusing \"Clade A\" with the first-order clades like 1A, 1B, 1C. However, the context doesn't mention a clade simply called \"A.\" \n\nGiven that, the answer would be that there's no information provided about Clade A in the context. The user might have made a mistake in referring to \"Clade A\" instead of one of the mentioned clades like 1A.1 or 1C.2. Since the question is based strictly on the provided context, and there's no mention of Clade A, the answer should state that the context does not provide information on Clade A.\n</think>\n\nThe provided context does not mention a clade specifically referred to as \"Clade A",
      "retrieved_chunks": [
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting.",
        "Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 .",
        "The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 ."
      ],
      "computed_relevance": 0.8,
      "computed_utilization": 0.8,
      "computed_completeness": 0.875,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look at the provided context. The context mentions that the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. Also, there's a note about the receptor binding domain (RBD) in the S1 subunit being highly conserved. \n\nWait, the first sentence in the context says that most bat SARS-related CoVs have deletions in the spike receptor binding domain compared to human SARS-CoV. But the 2019-nCoV's S2 subunit is highly conserved with 99% identity. However, the question is about the S1 subunit. \n\nThe passage states that the S1 subunit of 2019-nCoV shares about 70% identity with the bat SARS-like and human SARS-CoV. The core domain of RBD is conserved. So even though there's 70% identity overall, the RBD part is more conserved. \n\nI need to make sure I'm not mixing up S1 and S2. The S2 subunit is 99% identical, but S1 is 70%. The answer should focus on the S1 subunit's comparison. Also, the context mentions that in bat SARS-related CoVs like ZC45, some structures (like S5) are not found in the same location as in 2019-nCoV and SARS-CoV, but that's about S5 in orf1a/b, which might be part of S2 or another region. \n\nSo the key points are: 70% identity in S1 subunit between 2019-nCoV, bat SARS-like, and human SARS-CoV. The RBD core is highly conserved. Also, the S1 subunit's RBD might have some differences due to deletions in bat CoVs, but the 2019-nCoV's RBD is conserved. \n\nTherefore, the answer should state that the S1 subunit of 2019-nCoV",
      "retrieved_chunks": [
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b.",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "Title: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: Spike glycoprotein comprised of S1 and S2 subunits."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and they provided some context from a research paper titled \"Secretome of Intestinal Bacilli: A Natural Guard against Pathologies.\" \n\nFirst, I need to parse through the given passages to extract relevant information about Bacillus subtilis. The first passage mentions that Bacillus species, along with Lactobacillus, are found in traditional fermented foods and are used in probiotics like Biosubtyl, Biosporin, etc. It also states that probiotics have beneficial effects on intestinal function.\n\nThe second passage notes that Bacillus genus was not traditionally considered part of the normal intestinal microbiome, unlike Lactobacillus. However, they can be isolated from feces. This suggests that while they might not be permanent residents, they can be present in the gut.\n\nThe third passage gives specific details about B. subtilis. It mentions that B. subtilis produces surfactins, fengycins, and iturins in a 6:37:57 ratio. Additionally, it states that B. subtilis helps restore gut microflora balance by increasing beneficial bacteria (Bifidobacterium, Lactobacillus, Butyricicoccus) and reducing harmful ones (Acinetobacter, Ruminococcus, Clostridium, Veillonella). \n\nPutting this together, Bacillus subtilis is a species within the Bacillus genus. It's used as a probiotic, found in fermented foods, and has antimicrobial properties due to the compounds it produces. Its role in modulating gut microbiota by promoting beneficial bacteria and inhibiting pathogenic ones is highlighted. Also, it's part of commercial probiotic products. \n\nI need to make sure the answer includes its classification (Bacillus genus), its role as a probiotic, the specific compounds it produces, and its effects on gut health. Also, note that while it's used in probiotics, it wasn't traditionally considered part of the normal gut microbiome. The answer should be concise but cover these key points.\n</think>\n\nBacillus subtilis is a species within the *Bacillus* genus, historically recognized for its presence in traditional fermented foods and its use as a probiotic. It is not typically part of the normal intestinal microbiome but has been shown to colonize the gut",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B.",
        "subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 .",
        "subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp."
      ],
      "computed_relevance": 0.4444444444444444,
      "computed_utilization": 0.5555555555555556,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context titled \"The origins of the great pandemic,\" it mentions the 1889 pandemic with three major waves from 1889 to 1892, specifically noting the 1892 wave as the most intense. However, the question is about single-wave pandemics. This context might not be directly relevant unless there's a mention of single-wave scenarios. The passage also speculates about herald waves of the 1918 pandemic possibly starting in 1915, but again, the 1918 pandemic is known for multiple waves. So maybe not directly applicable here.\n\nNext, the second context about the 2009 pandemic in Hong Kong discusses convalescent plasma treatment and models. The passage mentions a study on the feasibility of convalescent plasma, but it's about treatment, not the structure of the pandemic waves. Not directly about single-wave.\n\nThird context is about influenza virus circulation in Taiwan from 2008-2014, focusing on the 2009 pH1N1 pandemic. It talks about multi-wave epidemics and using the Richards model to distinguish turning points. The passage mentions multi-wave scenarios, so this might not be about single-wave pandemics. However, there's a line that says \"when there is more than one wave of infections,\" which implies that single-wave is a contrast. But the study itself is on multi-wave, so maybe not helpful here.\n\nFourth context is an economic analysis of mitigation strategies for five pandemic severity categories. It references studies using individual-based simulation models. The passage doesn't mention wave patterns but focuses on economic strategies. Not directly related to single-wave pandemics.\n\nLooking again, maybe the first context's mention of the 1889 pandemic having three waves but the 1892 wave being the most intense. Wait, the user is asking about severe, single-wave pandemics. The 1889 example isn't single-wave. However, the passage suggests considering if herald waves of 1918 went back to 1915. The 1918 pandemic had multiple waves, so that's not it. \n\nWait, maybe there's a mention of single-wave in",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review.",
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al."
      ],
      "computed_relevance": 0.0,
      "computed_utilization": 0.875,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's try to figure out how many reported viral pneumonia cases there are based on the provided context. The user is asking for the total number of reported viral pneumonia cases. Let me go through each of the passages again to see if there's any mention of numbers related to viral pneumonia.\n\nFirst, the first context is about pneumonia in adults with influenza in the US from 2005-2008. It mentions that patients with pneumonia were more likely to receive antiviral therapy, but it doesn't give a specific number of cases. So probably not the answer here.\n\nThe second context is about the 2019-nCoV (now known as COVID-19) rapid advice guideline. The passage states that as of January 26, 2020, there were 2744 confirmed cases of pneumonia with 2019-nCoV infection in China. It also mentions 461 severe cases and 80 deaths. Then it says \"A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\" but the number isn't provided here. Wait, maybe the user is referring to the 2744 as the total? That seems like a specific number related to viral pneumonia caused by 2019-nCoV. Since the question is about reported viral pneumonia, this might be the key number.\n\nThe third and fourth contexts are about influenza viral pneumonia. The third one talks about bacterial co-infection in H1N1 cases, and the fourth gives attack rates but not specific numbers of cases. The numbers mentioned there are percentages, not actual counts. So those don't give a total number of reported cases.\n\nLooking back at the second passage, the only specific number given for viral pneumonia is 2744 confirmed cases of pneumonia with 2019-nCoV. The other numbers like 5794 suspected cases or 32,799 close contacts aren't confirmed viral pneumonia cases. The question is about reported viral pneumonia, which would be the confirmed cases. So the answer is likely 2744. Let me check again to make sure I didn't miss any other numbers. The other contexts don't mention specific numbers for viral pneumonia beyond that. So yes, the answer should be 2744.\n</think>\n\nThe context provided mentions that as of January 26, 2",
      "retrieved_chunks": [
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation."
      ],
      "computed_relevance": 0.1111111111111111,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, the first sentence says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The key terms here are \"high throughput\" and \"deep sequencing methods.\" \n\nI should check the other passages to make sure there's no conflicting information. The second passage mentions genetic recombination studies but doesn't talk about the primary method. The third passage discusses genome analyses and specific regions like the spike protein, but again, the method isn't mentioned there. The fourth passage emphasizes vigilance and data sharing but not the analysis method. \n\nSo the answer is definitely from the first passage. High throughput or deep sequencing is the main technique used. The user might be looking for confirmation that this method is the primary one, and the context clearly states that. I need to present this answer concisely, quoting the exact methods mentioned.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods** for complete genome deduction. This approach was highlighted as the first widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective.",
        "The technique can produce genomic ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided context to find the relevant information.\n\nFirst, looking at the first context about Enterovirus, they mention using a split-GFP-tagged viral protein. They talk about imaging one color channel where GFP-expressing cells are white and others black. But the question is about tracking the spread, so maybe that's part of it. However, the second context is about Influenza A viruses with reporter genes. There's a passage that says they used IVIS for whole-organ imaging in the lungs of infected mice, and also flow cytometry to analyze infection progression in antigen-presenting cells. They also mention imaging murine lungs showing infection starting near large airways and spreading deeper. \n\nSo the answer probably involves IVIS for whole-organ imaging and flow cytometry. Also, immunofluorescence microscopy was used during passaging. But the question is specifically about tracking the spread. The key part is in the second context: \"Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression...\" So IVIS and flow cytometry are the methods used. Additionally, they imaged the lungs to see the spread from airways to deeper sections. \n\nWait, the answer should be concise. The main methods are IVIS for whole-organ imaging and flow cytometry. Also, maybe immunofluorescence microscopy? But the question is about tracking the spread, which would be over time. The passage says they monitored expression during passaging with immunofluorescence, but tracking spread in the lungs would be through imaging. So the answer is using IVIS for whole-organ imaging and flow cytometry. Let me check again. The exact sentence: \"Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells.\" So those two methods. Also, the imaging of murine lungs showed the spread pattern. But the tracking method would be IVIS and flow cytometry. So the answer should mention those two techniques.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using **IVIS (In",
      "retrieved_chunks": [
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator .",
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black .",
        "Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs .",
        "Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody.",
        "For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution."
      ],
      "computed_relevance": 0.7142857142857143,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 0.4,
      "computed_adherence": 0.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages related to CT disinfection procedures. \n\nFirst, I need to look through the given context. The titles all mention \"The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management,\" so the content is likely about protocols for handling medical equipment in such scenarios.\n\nLooking at the passages:\n\n1. \"Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\"\n2. \"Fever-CT disinfection procedures after examination\"\n3. \"fever-CTs) after these sterilization procedures.\"\n4. \"equipment and prepares to disinfect the imaging equipment immediately after the examination.\"\n\nFrom these, the key points seem to be that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The terms \"immediately after the examination\" and \"sterilization procedures\" are mentioned. Also, the mention of \"fever-CTs\" might refer to CT scanners used specifically for patients with fever, which is a common symptom of COVID-19.\n\nThe answer should combine these elements. The recommended procedure is to disinfect the CT scanner immediately after the examination of a suspected or confirmed COVID-19 case. The exact steps might involve using appropriate sterilization methods, but the context doesn't specify the exact disinfectants or steps beyond the timing and the fact that it's done right after the exam. Since the user is asking for the procedure, the answer should highlight the immediate disinfection post-examination as the key step, possibly mentioning sterilization procedures as part of the process.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment after the examination** of a suspected or confirmed COVID-19 case. The context emphasizes that sterilization/ disinfection protocols should be performed promptly to prevent contamination, particularly for CT scanners used in cases involving fever or suspected infections. Specific steps likely include using approved disinfectants and following established sterilization procedures tailored for medical imaging equipment.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}